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Abstract 
BACKGROUND: Research done globally on hepatitis E virus (HEV) infection is far fewer compared with other 
types of hepatitis virus infection. Little is known on the prevalence of HEV in Nigeria. 
AIM: The present study presents the prevalence of HEV infection in Nigeria from a few available research papers 
on HEV. The detailed statistical analysis was used to analyse the prevalence of HEV in humans and animals. 
MATERIAL AND METHODS: A literature search in Web of Science, Scopus and PubMed databases was done, 
and a final 7 articles were selected. Minitab 17.0 was used to perform the correlational and binary logistic 
analyses. 
RESULTS: Serum and faecal analysis of blood and stool samples of 1178 humans and 210 pigs (animals) were 
done, and the presence of anti-HEV IgG or HEV RNA in the study samples were 127 and 138 respectively. 
Further analysis showed the prevalence of HEV are 10.8% and 65.7% in humans and animals, respectively. 
Weak positive non-significant association (r = 0.327, p-value = 0.474) was obtained between the target (humans 
and animal) and the HEV infection (positive) groups. The application of binary logistic regression yielded an 
equation that can be used to predict the target group from the HEV positive humans or animals. Generally, the 
logistic model was not statistically significant (p-value = 0.376), and the model was able to explain 9.3% of the 
deviation or variability of the model. The odds ratio is OR = 1.0344 with 0.9550, 1.204 95% Confidence Interval 
(CI). Thus, in Nigeria, the odds of prevalence of HEV in animals are 1.0344 higher than humans. 
CONCLUSION: The risk factors obtained from the few available articles are consistent with the global 
epidemiology of HEV infection. Food and animal handlers and those that consume unsafe water are the key 
people at risk of HEV infection in Nigeria. 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Hepatitis E is an inflammatory liver disease 
caused by a non-enveloped positive-sense [1] and 
single-stranded ribonucleic (RNA) genome called the 
hepatitis E virus (HEV). The virus is in four different 
types identified as genotypes 1, 2, 3 and 4. 
Genotypes 1 and 2 have been isolated in humans 
while 3 and 4 are found in animals. HEV is transmitted 
mainly through faecal contamination of drinking water 
and uncooked foods. Generally, the risk factors of the 
disease include lack of access to cheap, safe and 
potable drinking water, unhygienic living conditions 
and indiscriminate disposal of human wastes, poverty, 
the insecurity that results to a strain on access to 
basic life amenities and limited access to quality 
health services [2]. Symptoms of the disease include 
mild fever, anorexia, nausea, jaundice, dark urine, 
pale stools and slight liver inflammation, although, 
rare cases have been reported to result to fulminant 
hepatitis in pregnant women [3], [4]. Diagnosis of HEV 
infection includes detection of the HEV in stool or 
serum samples and serological tests for identification 
of anti-HEV Ig G and Ig M [1]. Measures to be taken 
to eliminate the risk factors are consistent supply of 
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clean and safe water, improving personal hygiene and 
ensuring proper disposal of human wastes.  
Hepatitis E is one of five known human 
hepatitis viruses. Others are A [5], B [6], [7], C [8], [9], 
[10] and D [11]. The prevalence of HEV is very low 
compared with the others, especially hepatitis B virus 
(HBV). Numerous articles that investigated different 
aspects of HBV infections in Nigeria [12], [13], [14] 
and few papers are available for HEV infection.  
This paper aims to present a statistical 
analysis of a few articles published on the prevalence 
of HEV infection in Nigeria. The few papers are 
traceable to the low prevalence of the disease in the 
world of which the studied country is a particular case. 
A similar investigation has been done and can be 
found in [15], [16], [17], [18], [19], [20], [21].  
 
 
Material and Methods 
 
Study Design 
The study design is Web of Science, Scopus 
and PubMed databases. The keywords "Hepatitis E" 
OR "HEV" AND “Nigeria” were queried in Scopus, 
PubMed and Web of Science databases. PubMed, 
Scopus and Web of Science (WOS) returned 301, 66 
and 11 articles respectively. Further evaluation 
showed that the articles in WOS are also contained in 
Scopus and are littered with hepatitis B and studies on 
areas not related to Nigeria. A final seven (7) articles 
were sieved out after all the unrelated articles were 
removed.  
 
Eligibility Criteria 
The papers that contained the prevalence of 
HEV in their abstracts were included. Risk of bias was 
almost nonexistent since the sample size is small.  
 
Ethics Statement 
No ethical rules were violated. All the sources 
of information were duly acknowledged.  
 
Statistical Analysis  
The absence of numerous studies places 
undue restrictions on the use of different statistical 
techniques. The statistical techniques are needed to 
reveal hidden patterns as long as the sample size is 
appreciably high [22], [23], [24], [25], [26], [27], [28]. 
The 7 articles were analysed using Minitab version 
17.0, binary logistic regression was used for the 
analysis, and this was as a result of splitting of the 
target groups into two distinct and non-overlapping 
classes. P-value of 0.05 was considered significant.  
 
 
Results 
 
The summary of the data presentation of the 
7 articles [29], [30], [31], [32], [33], [34], [35] are 
presented in Table 1. The publication span 10 years. 
It can be seen that (6/7) of both the methodology and 
diagnostics (tool for analysing serum and faecal 
samples) used in the articles are cross-sectional 
studies and enzyme-linked immunosorbent assay 
(ELISA) technique respectively.  
Table 1: Studies on hepatitis E virus infection in Nigeria 
Author Publication 
Year 
Methodology Target Group Diagnost
ics 
Sample 
size 
HEV 
positive 
[29] 2008 Observation Hospitalized Therapy 1 1 
[30] 2013 Cross sectional Non-hospitalized ELISA 132 36 
[31] 2014 Cross sectional Pigs ELISA 90 69 
[32] 2014 Cross sectional Non-hospitalized ELISA 462 43 
[33] 2015 Cross sectional Non-hospitalized ELISA 406 31 
[34] 2018 Cross sectional Pigs ELISA 120 69 
[35] 2018 Cross sectional Non-hospitalized ELISA 177 16 
 
Prevalence of HEV in the samples 
HEV positive means the presence of anti-HEV 
IgG or HEV RNA in the study samples. The 
prevalence for each case is obtained using the 
dataset of Table 1, by dividing the total number of 
HEV positive and the total number investigated and 
multiplying by 100. This is presented in Table 2. 
Table 2: Prevalence of the two types of HEV infection in Nigeria 
 Humans Animals 
Total investigated 1178 210 
HEV positive 127 138 
Prevalence 10.8% 65.7% 
 
 
Correlation Analysis 
Correlation coefficient was obtained between 
the target group (humans = 0, animal = 1) and the 
HEV positive and it was computed to be (r = 0.327, p 
= 0.474). 
 
Binary Logistic Regression 
 Binary logistic regression was performed to 
determine the association between the target group y 
(humans = 0, animal = 1) and the HEV positive (x).  
 
Table 3: Deviance table 
Source DF Adj Dev Adj Mean Chi-Square P-Value 
Regression 1 0.7842 0.7842 0.78 0.376 
Error 5 7.5915 1.5183 
Total 6 8.3758 
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 This is to determine if the prevalence of HEV 
can predict whether the target group is animal or 
human.  
Table 4: Model Summary 
Deviance Deviance 
 R-Sq R-Sq(adj) AIC 
 9.36% 0.00% 11.59 
 
 The details are presented in Tables 3 to 7, 
and the logistic regression equation is Exp(y) = -
2.33+0.338x. 
 
Table 5: Coefficient of the model 
Term Coef SE Coef VIF 
Constant -2.33 2.04 
x 0.0338 0.0407 1.00 
 
 
 
Discussion 
 
The few available studies on HEV infection in 
Nigeria is due to the less severe nature of the disease 
when compared with Hepatitis B infection. The low 
research activities on HEV can also be as a result of 
the low incidence of the disease, self-medication, the 
use of traditional or alternative medicine and non-
hospitalization. Hospital records about the HEV 
infection will encourage cross-sectional and 
retrospective studies.  
Table 6: Odds Ratios for Continuous Predictors 
 Odds Ratio 95% CI 
x 1.0344 (0.9550, 1.1204) 
 
The risk factors available from the few articles 
are consistent with the global epidemiology of HEV 
infection. The risk factors are faecal contamination of 
water and food, improper disposal of human and 
animal wastes, poverty, unhygienic environment and 
inadequate access to quality healthcare services.  
Table 7: Goodness-of-Fit Tests 
Test DF Chi-Square P-Value 
Deviance 5 7.59 0.180 
Pearson 5 6.61 0.252 
Hosmer-Lemeshow 4 4.60 0.330 
 
Serum and faecal analysis of blood and stool 
samples of 1178 humans and 210 pigs (animals) were 
done, and the presence of anti-HEV IgG or HEV RNA 
in the study samples were 127 and 138 respectively. 
Further analysis showed the prevalence of HEV are 
10.8% and 65.7% in human and animals, respectively. 
The high level of the prevalence in animals calls for 
urgent action to avoid infections to human via faecal 
oral transmission.  
There is a weak positive non-significant 
association between the target groups (humans and 
animals) and the HEV infection (positive). This is the 
outcome of the prevalence that showed that the 
prevalence of both groups is different; that is, high for 
animals and low for humans.  
The application of binary logistic regression 
yielded an equation that can be used to predict the 
target group from the HEV positive humans or 
animals. Generally, the logistic model was not 
statistically significant (p-value = 0.376), and the 
model was able to explain only 9.3% of the deviation 
or variability of the dependent variable. The odds ratio 
was gotten to be; OR = 1.0344 (0.9550, 1.204) 95% 
CI. Thus, in Nigeria, the odds of prevalence of HEV in 
animals are 1.0344 higher than humans.  
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